Published on: January 2023 

Indian Journal of Pharmacy Practice, 2023; 16(1):65-68 

Case Report | doi:10.5530/097483261419  


 Riya Johns*, Dharitri G Joshi, Asha Mathew

Department of Pharmacy Practice, Bapuji Pharmacy College, Shamanur Road, S.S Layout, Davangere, Karnataka, INDIA.


Nephrotic syndrome is a kidney condition that affects the kidney’s glomeruli and causes protein to be excreted in the urine. In paediatric population, the drug of choice for nephrotic syndrome is prednisolone which resolves the signs and symptoms. Prednisolone is a corticosteroid that acts on the immune system to reduce inflammation, swelling, and redness. The International Study of Kidney Disease in Children (ISKDC) proposed a standard initial treatment for children with nephrotic syndrome, consisting of prednisolone therapy for 8 weeks. This case report presents a 4-year-old female patient was presented to the hospital with the complaints of decreased urine output, increased albumin levels (6.8g/dl) and increased protein concentration(15.5mg/m2/day). Tab. Prednisolone (2mg/kg/day) was administered to the patient. After tapering the dose of Prednisolone, the patient again showed proteinuria (400mg/m2/day). Upon restarting the Tab.Prednisolone the urine protein concentration came back to normal levels. Therefore, it is summarized that despite being the first-line drug prednisolone can also cause steroid dependence in patients with nephrotic syndrome. An alternative therapy should be implied along with dose tapering. This implies a wide role for clinical pharmacists in the therapeutic evaluation among paediatric patients.

Keywords: Prednisolone, Nephrotic Syndrome, Steroid Dependent Nephrotic Syndrome, Proteinuria, Tapering of the dose.